Wuxi AppTec-Related Shares Tumble on Proposed U.S. Bill Aimed at Chinese Biotech Companies
Wall Street Journal
Shares of Wuxi AppTec and Wuxi Biologics tumbled Friday amid concerns a proposed U.S. bill would restrict medical providers from business with certain Chinese biotechnology companies.